The main objective of this training program in The Molecular Genetics of Cancer is to prepare predoctoral (4) and postdoctoral (5) trainees for careers in cancer research. The training program is based at the world renowned M. D. Anderson Cancer Center. Faculty are collegial and interactive, and belong to five departments, one clinical, with cross appointments in other clinical departments. The interests of the faculty include the study of tumor suppressors (p53, PTEN, WT1, Brca1), genetic modifiers of the cancer phenotype, inherited cancer syndromes, the DNA damage response, DNA recombination and repair, telomere biology, genomic instability, cell regulation, chromatin modification in cancers, and regulators of cell proliferation and apoptosis. The faculty use genetic and biochemical assays, animal models and human samples to understand the normal and abnormal mechanisms that govern cell proliferation and death. Trainees will choose a research mentor of their choice, and submit their applications to open training grant positions. If highly qualified, they will be selected and supported for a maximum of three years with annual review. Trainees will attend classes and receive instruction in the responsible conduct of research. They will attend seminars, journal clubs, and the annual program retreat. They will learn presentation and grant writing skills. They will be encouraged to attend and present at national meetings. The faculty and the interactive environment of MDACC and the Texas Medical Center will stimulate trainees to achieve a life long commitment to Making Cancer History"""""""".
An estimated 565,000 Americans will die of cancer this year. The complexity and heterogeneity of the cancer phenotype, the existence of multiple pathways that control cell proliferation and death suggest that cancer is an individual disease. We have much to learn.
|Gonzalez, Gabriel; Mehra, Shyamin; Wang, Ying et al. (2016) Sox9 overexpression in uterine epithelia induces endometrial gland hyperplasia. Differentiation 92:204-215|
|Jung, Kwang Hwa; McCarthy, Ryan L; Zhou, Chong et al. (2016) MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1. Stem Cells 34:1284-96|
|Palculict, Timothy Blake; Ruteshouser, E Cristy; Fan, Yu et al. (2016) Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour. J Med Genet 53:385-8|
|Ungewiss, Christin; Rizvi, Zain H; Roybal, Jonathon D et al. (2016) The microRNA-200/Zeb1 axis regulates ECM-dependent Î²1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL. Sci Rep 6:18652|
|Jain, Abhinav K; Xi, Yuanxin; McCarthy, Ryan et al. (2016) LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56. Mol Cell 64:967-981|
|Riley, M F; You, M J; Multani, A S et al. (2016) Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma. Oncogene 35:358-65|
|Phan, Liem; Chou, Ping-Chieh; Velazquez-Torres, Guermarie et al. (2015) The cell cycle regulator 14-3-3Ïƒ opposes and reverses cancer metabolic reprogramming. Nat Commun 6:7530|
|Im, Seol Hee; Takle, Kendra; Jo, Juyeon et al. (2015) Tachykinin acts upstream of autocrine Hedgehog signaling during nociceptive sensitization in Drosophila. Elife 4:e10735|
|Phan, Liem M; Fuentes-Mattei, Enrique; Wu, Weixin et al. (2015) Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res 75:4131-42|
|Klein, Brianna J; Piao, Lianhua; Xi, Yuanxin et al. (2014) The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep 6:325-35|
Showing the most recent 10 out of 56 publications